oid_b16b3aea-8163-ea11-a811000d3a24e4ce_Vector Bioscience logo-nobackground-5000.png

Vector Bioscience Cambridge

R&D

  • Funding stage: Series A
  • Technology type: Platform Technology
Membership category
Emerging Y1

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, United Kingdom

Vector Bioscience Cambridge at a glance

Transforming Drug Delivery with Next-Generation Nanotechnology

About Vector Bioscience Cambridge

Vector Bioscience is pioneering a next-generation drug delivery platform to overcome the limitations of current therapeutics. Our NanoShuttle technology enables precise, efficient, and controlled delivery of a wide range of therapeutics, including small molecules, biologics and their combinations, addressing key challenges such as poor bioavailability, off-target toxicity, and limited drug stability.

With unmatched loading capacity, tunability, and biocompatibility, our platform offers a versatile, scalable solution for pharma  partners seeking to optimise drug formulations and reduce side effects. Supported by a strong IP portfolio and AI-driven formulation design, Vector is working to enable the next wave of precision medicine.


Therapeutic area(s)

Articles Vector Bioscience Cambridge has contributed to